Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
{{output}}
Background: Transthyretin amyloid cardiomyopathy is a progressive disease with a poor prognosis. There had been no specific treatment for transthyretin amyloid cardiomyopathy until tafamidis received expanded approval in March 2019 in Japan. However, the clini... ...
